ACH has undergone a dramatic business transformation, rebranding from Owens Minor to focus exclusively on home healthcare services through its Apria and Byram Healthcare brands.
The company has fundamentally restructured from a global healthcare distribution business serving 80 countries to a specialized U.S.-focused home healthcare provider. This represents a complete strategic pivot that eliminates the previous Products Healthcare Services segment and concentrates entirely on direct patient care for chronic and complex conditions.
The financial statements reflect a dramatic downsizing consistent with the strategic transformation, with revenue substantially reduced alongside corresponding decreases in inventory, current assets, and total assets. Operating cash flow declined significantly, though the company reduced its debt burden and SG&A expenses as part of the restructuring. The overall financial profile suggests ACH has divested major portions of its former distribution business to focus on a much smaller but specialized home healthcare operation.
Inventory drawn down 93.4% — strong sell-through or deliberate destocking; watch for supply constraints.
Operating cash flow fell 78.2% — earnings quality concerns; investigate working capital changes and non-cash items.
Revenue declined 74.2% — significant demand weakness or market share loss warrants investigation.
Current assets declined 72.9% — monitor working capital adequacy and short-term liquidity.
Current liabilities reduced — improved short-term financial position and working capital health.
Total assets contracted 47.3% — asset sales, write-downs, or balance sheet optimization underway.
SG&A reduced 44.1% — improved cost efficiency or headcount reduction improving operating margins.
Debt reduced 34.2% — deleveraging strengthens balance sheet and reduces financial risk.
Liabilities reduced 28.8% — deleveraging improves balance sheet strength and financial flexibility.
Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →